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Abstract
Background: Rhodococcus equi is an important pathogen of foals. Enteral administration of live, virulent R. equi during early
life has been documented to protect against subsequent intrabronchial challenge with R. equi, indicating that enteral
mucosal immunization may be protective. Evidence exists that mucosal immune responses develop against both live and
inactivated micro-organisms. The extent to which live or inactivated R. equi might alter the intestinal microbiome of foals is
unknown. This is an important question because the intestinal microbiome of neonates of other species is known to change
over time and to influence host development. To our knowledge, changes in the intestinal microbiome of foals during early
life have not been reported. Thus, the purpose of this study was to determine whether age (during the first month of life) or
administration of either live virulent R. equi (at a dose reported to protect foals against subsequent intrabronchial challenge,
viz., 161010 colony forming units [CFU]) or inactivated virulent R. equi (at higher doses, viz., 261010 and 161011 [CFU])
altered the fecal microbiome of foals.
Methodology/Principal Findings: Fecal swab samples from 42 healthy foals after vaccination with low-dose inactivated R.
equi (n = 9), high-dose inactivated R. equi (n = 10), live R. equi (n = 6), control with cholera toxin B (CTB, n = 9), and control
without CTB (n = 8) were evaluated by 454-pyrosequencing of the 16S rRNA gene and by qPCR. No impact of treatment was
observed among vaccinated foals; however, marked and significant differences in microbial communities and diversity were
observed between foals at 30 days of age relative to 2 days of age.
Conclusions: The results suggest age-related changes in the fecal microbial population of healthy foals do occur, however,
mucosal vaccination does not result in major changes of the fecal microbiome in foals.
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Introduction
Rhodococcus equi is a facultative intracellular pathogen that
primarily infects macrophages [1]. Although human beings may
be infected (primarily those who are immunocompromised by
HIV infection or immunosuppressive treatments), R. equi is most
commonly recognized clinically as a leading cause of severe
pneumonia in foals [1–4]. The disease occurs among foals
worldwide [1–4]. Isolates that are virulent in foals bear a plasmid
that encodes for a pathogenicity island, which includes the gene
for the virulence-associated protein A (vapA); vapA is necessary
but not sufficient to cause disease [5,6].
Despite the global importance of the disease, an effective
vaccine is lacking for control and prevention of R. equi pneumonia
in foals. The lack of an effective vaccine is likely attributable to the
complexity of immunity to R. equi [7–9], and the finding that foals
appear to be infected very early in life [10,11], when immune
responses are naı¨ve or deficient. It is generally accepted that a
vaccine must be able to provide foals with protection against
infection with R. equi during early life [5].
To date, the only vaccination strategy that has been demon-
strated repeatedly to be effective for protecting against experi-
mental intrabronchial challenge with virulent R. equi has been oral
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administration of live, virulent R. equi [12–14]. Protection against
respiratory pathogens induced by oral vaccination also has been
documented in mice [15–17], and evidence exists that bacillus
Calmette-Guerin (BCG) administered orally is protective against
tuberculosis in people and animals [18–20]. Moreover, inactivated
bacteria and viruses also can elicit protective immune responses
against systemic infections, including those of the respiratory tract
[21–24]. Despite the success of oral administration of live
organisms to protect foals against experimental challenge, very
limited information is available regarding immune and other
biological responses to the enteral route of vaccination.
One issue of importance with regard to enteral vaccination with
live organisms is the impact of enteral administration of bacteria
on the intestinal microbiome. This question might be particularly
important for neonates. Although the microbiome of foals has not
been systematically evaluated, evidence exists in other species,
including humans, that the intestinal microbiome of neonates
develops with age [25–27], and is linked to the functional
development of the gut and gut immunity [25–29]. Thus, the
purpose of the study reported here was to determine whether age-
related changes in the microbiome occur in foals and whether age-
associated changes are impacted by administration of either live
virulent R. equi at a dose documented to protect foals against
experimental challenge or 2 doses of inactivated virulent R. equi
higher than the dose of live R. equi.
Materials and Methods
Ethics statement
All procedures for this study, including collection of rectal swab
samples and enteral treatments/vaccinations, were reviewed and
approved by the Texas A&M University Institutional Animal Care
and Use Committee (protocol number AUP # 2011-124) and the
Texas A&M University Institutional Biosafety Committee (permit
number 20110183-Cohen). The foals used in this study are owned
by Texas A&M University, and permission for their use was
provided in compliance with the Institutional Animal Care and
Use Committee procedures.
Animals and housing
Forty-two healthy Quarter Horse foals were used for this study.
All foals were born healthy and had age-appropriate results of
complete blood count (CBC) on day 2 of life, and adequate
transfer of passive immunity as assessed by a commercially-
available qualitative immunoassay for serum concentration of total
IgG (SNAP Foal IgG test; IDEXX, Inc., Westbrook, ME). The
foals were assigned into 1 of 5 experimental groups prior to birth
(please see section on Vaccine Preparation and Treatment Groups
below). All foals were monitored daily by Texas A&M University
Horse Center staff for clinical signs of disease, and inspected at
least twice weekly by a veterinarian for clinical signs of disease. All
foals remained free of clinical signs of disease and in good health
throughout the study.
Mare Diet
The respective dams were fed 6.4 kg per horse per day of a 13%
horse pellet (crude protein: 13.5%; crude fat: 4.5%; crude fiber:
10%). Also, the foals and their mares were allowed free access to
coastal Bermuda grass hay, plus grazing of pastures at the Texas
A&M University Horse Center where the mares were maintained.
Vaccine Preparation and Treatment Groups
Rhodococcus equi strain EIDL 5-331, obtained from a Texas foal
confirmed to have R. equi pneumonia, was used to prepare live and
inactivated vaccines used for this project. Physiological saline
(NaCl 0.9%) was used as a diluent to achieve the specified
concentration of all vaccine preparations, as well as for the
negative control. The vaccine was produced by inoculating blood
agar plates with 1 colony forming unit (CFU) of R. equi strain 5-331
and incubating at 37uC for 48 hours. One colony from this pure
culture was selected and used to inoculate 1,000 ml of brain heart
infusion (BHI, BactoTMBrain Heart Infusion, BD Diagnostic
Systems, Sparks, MD) broth. The flask with inoculated broth was
placed on an orbital shaker (VWR OS-500, VWR, Radnor, PA) at
200 rpm for 24h at 37uC to allow bacterial growth. Isolates were
repeatedly tested by PCR for the vapA gene to confirm that the
isolates were virulent [30]. The bacterial culture was inactivated
by electron-beam irradiation (irradiation dose between 3.5 and
5 kGy). After inactivation, the irradiated bacterial cells were plated
out on BHI agar plates and incubated for 2 weeks at 37uC to
confirm inactivation.
The number of foals in each group was determined a priori, and
foals were assigned randomly to each of the groups. The study
groups were as follows: 1) low-dose inactivated virulent R. equi
group (n = 9), receiving 261010 CFUs of inactivated R. equi
combined with 100 mg of cholera toxin subunit B (CTB, List
Biological Laboratories, Campbell, CA) as a mucosal adjuvant,
diluted in 100 ml of saline administered via nasogastric intubation;
2) high-dose inactivated virulent R. equi group (n = 10), receiving
Table 1. Oligonucleotide primers/probes used for this study.
qPCR primers/probe Sequence (59- 39) Target Annealing (6C) Reference
CFB555f CCGGAWTYATTGGGTTTAAAGGG Bacteroidetes 60 56
CFB968r GGTAAGGTTCCTCGCGTA
Fuso-F KGGGCTCAACMCMGTATTGCGT Fusobacteria 51 26
Fuso-R TCGCGTTAGCTTGGGCGCTG
341-F CCTACGGGAGGCAGCAGT Universal Bacteria 59 57
518-R ATTACCGCGGCTGCTGG
EntF CCCTTATTGTTAGTTGCCATCATT Enterococcus 61 58
EntR ACTCGTTGTACTTCCCATTGT
EcolRT_F GTTAATACCTTTGCTCATTGA E. coli 55 59
EcolRT R ACCAGGGTATCTAATCCTGTT
doi:10.1371/journal.pone.0066640.t001
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161011 CFUs of inactivated R. equi with 100 mg of CTB diluted in
100 ml of saline via nasogastric intubation; 3) live virulent R. equi
group (n = 6), receiving 161010 CFUs of live R. equi diluted in
100 ml of saline administered via nasogastric intubation; 4) control
with CTB group (n = 9), receiving 100 mg of CTB diluted in
100 ml of saline via nasogastric intubation; and, 5) control without
CTB group (n = 8), receiving 100 ml of saline via nasogastric
intubation. Treatments (i.e., live bacteria, inactivated bacteria, and
negative controls) were administered by nasogastric intubation to
foals at 2, 9, 16, and 23 days of age.
Fecal swabbing
Rectal swabs were collected by inserting a 16-inch, cotton-
tipped swab that was pre-moistened with 3 ml of sterile saline
Figure 1. Rarefaction analysis of 16 S rRNA gene sequences obtained from fecal swabs from foals. Lines represent the average of each
vaccination group at all ages (panel A) or at 30 days only (panel B), while the error bars represent the standard deviations. The analysis was performed
on a randomly selected subset of 1,300 sequences per sample and included samples from 42 foals. Note that both the greatest and least number of
species observed occurred among foals that received no enteral bacteria (live or inactivated), indicating an absence of evidence of treatment effect.
Control = control plus CTB group; Control_no_CTO = control without CTB group; High = high-dose inactivated R. equi group; Live = live R. equi
group; Low = low-dose inactivated R. equi group.
doi:10.1371/journal.pone.0066640.g001
Figure 2. Rarefaction analysis of 16 S rRNA gene sequences obtained from fecal swabs from foals. Lines represent the average numbers
obtained at each age (legend numbers refer to the age in days), while the error bars represent the standard deviations. The analysis was performed
on a randomly selected subset of 1,300 sequences per sample and included samples from 42 foals. Note the progressive increase in observed species
(representing microbial diversity) with sequential age. The numbers for the legend represent age (in days).
doi:10.1371/journal.pone.0066640.g002
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Table 2. Median and range percentages of sequences represented in the fecal DNA of rectal swab samples from foals (Phylum,
class, order, and family).
Microbial Phylum/Class/Order/Family 2-day-old foals (N=37) 30-day-old foals(N =37) P*
Archaea.Euryarchaeota 0% (0%) 0% (0 to 0.6%) 0.0048
Methanobacteria 0% (0%) 0% (0 to 0.3%) 0.0280
Methanobacteriales 0% (0%) 0% (0 to 0.3%) 0.0924
Methanobacteriacae 0% (0%) 0% (0 to 0.3%) 0.1932
Methanomicrobia 0% (0%) 0% (0 to 0.6%) 0.1341
Methanomicrobiales 0% (0%) 0% (0 to 0.6%) 0.4321
Methanocorpusculaceae 0% (0%) 0% (0 to 0.6%) 0.9089
Bacteria.Acidobacteria 0% (0%) 0% (0 to 0.2%) 0.9515
Acidobacteria 0% (0%) 0% (0 to 0.2%) 1.0000
Acidobacteriales 0% (0%) 0% (0 to 0.2%) 1.0000
Acidobacteriaceae 0% (0%) 0% (0 to 0.2%) 1.0000
Bacteria.Actinobacteria 0.2% (0 to 4.1%) 1.2% (0 to 4.3%) 0.0048
Actinobacteria 0.2% (0 to 4.1%) 1.2% (0 to 4.3%) 0.0280
Actinomycetales 0.1% (0 to 3.4%) 0.3% (0 to 2.8%) 0.3904
Bifidobacteriales 0% (0 to 0.2%) 0% (0 to 0.2%) 1.0000
Other 0% (0 to 0.7%) 0% (0 to 1.5%) 1.0000
Coriobacteridae (subclass) 0% (0 to 1.5%) 0.2% (0 to 2.7%) ,0.0001
Coriobacteriales 0% (0 to 1.5%) 0.2% (0 to 2.7%) 0.0080
Rubrobacteridae (subclass) 0% (0 to 0.7%) 0% (0%) 0.9515
Rubrobacterales 0% (0 to 0.7%) 0% (0%) 1.0000
Other order 0% (0%) 0% (0 to 0.8%) 0.0578
Other family 0% (0%) 0% (0 to 0.8%) 0.1190
Bacteria.Bacteroidetes 16.7% (0 to 85.5%) 40.6% (0.2 to 87.8%) 0.0066
Bacteroidetes 16.7% (0 to 85.4%) 25.3% (0.1 to 80.5%) 0.5376
Bacteroidales 16.7% (0 to 85.4%) 25.3% (0.2 to 80.5%) 0.9515
Bacteroidieacae 16.7% (0 to 85.3%) 5.2% (0 to 53.3%) 1.0000
Porphyromonadaceae 0% (0 to 9.0%) 0.4% (0 to 16.4%) 0.0080
Prevotellaceae 0% (0 to 1.5%) 2.8% (0 to 63.1%) ,0.0001
Rikenellaceae 0% (0 to 10.2%) 0% (0 to 5.8%) 0.2108
Other 0% (0 to 0.2%) 4.0% (0 to 18.0%) ,0.0001
Flavobacteria 0% (0 to 1.2%) 0% (0 to 2.3%) 0.8167
Flavobacteriales 0% (0 to 1.2%) 0% (0 to 2.3%) 1.0000
Flavobacteriaceae 0% (0 to 1.2%) 0% (0 to 2.3%) 1.0000
Sphingobacteria 0% (0 to 0.2%) 0% (0 to 0.1%) 0.8167
Sphingobacteriales 0% (0 to 0.2%) 0% (0 to 0.1%) 0.9515
Crenotrichaceae 0% (0 to 0.1%) 0% (0%) 1.0000
Flexibacteriaceae 0% (0%) 0% (0 to 0.1%) 1.0000
Sphingobacteriaceae 0% (0 to 0.2%) 0% (0%) 1.0000
Other class 0% (0 to 1.7%) 5.5% (0 to 48.1%) ,0.0001
Other order 0% (0 to 1.7%) 5.5% (0 to 48.1%) ,0.0001
Other family 0% (0 to 1.7%) 5.5% (0 to 48.1%) ,0.0001
Bacteria.Chlamydiae 0% (0%) 0% (0 to 30.1%) ,0.0001
Chlamydiae 0% (0%) 0% (0 to 30.1%) ,0.0001
Chlamydiales 0% (0%) 0% (0 to 30.1%) ,0.0001
Chlamydiaceae 0% (0%) 0.1% (0 to 30.1%) ,0.0001
Parachlamydiaceae 0% (0%) 0% (0 to 0.1%) 1.0000
Bacteria.Chloroflexi 0% (0%) 0% (0 to 0.2%) 0.0441
Anaerolineae 0% (0%) 0% (0 to 0.2%) 0.2254
Caldilineae 0% (0%) 0% (0 to 0.2%) 0.9515
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Table 2. Cont.
Microbial Phylum/Class/Order/Family 2-day-old foals (N=37) 30-day-old foals(N =37) P*
Caldilineales 0% (0%) 0% (0 to 0.2%) 1.0000
Other 0% (0%) 0% (0 to 0.2%) 0.2635
Other family 0% (0%) 0% (0 to 0.2%) 0.5355
Bacteria.Cyanobacteria 0% (0%) 0% (0 to 0.1%) 0.9515
Cyanobacteria 0% (0%) 0% (0 to 0.1%) 1.0000
Other order 0% (0%) 0% (0 to 0.1%) 1.0000
Other family 0% (0%) 0% (0 to 0.1%) 1.0000
Bacteria.Deferribacteres 0% (0% to 0.2%) 0% (0 to 0.2%) 0.9515
Deferribacteres 0% (0% to 0.2%) 0% (0 to 0.2%) 1.0000
Deferribacterales 0% (0% to 0.2%) 0% (0 to 0.2%) 1.0000
Deferribacteraceae 0% (0%) 0% (0%) NP
Incertae sedis 3 0% (0 to 0.2%) 0% (0 to 0.2%) 1.0000
Bacteria.Fibrobacteres 0% (0%) 0% (0 to 0.7%) 0.2104
Fibrobacteres 0% (0% to 0.2%) 0% (0 to 0.7%) 0.4698
Fibrobacterales 0% (0% to 0.2%) 0% (0 to 0.7%) 0.9515
Fibrobacteraceae 0% (0% to 0.2%) 0% (0 to 0.7%) 1.0000
Bacteria.Firmicutes 40.4% (5.8 to 69.2%) 23.3% (4.4 to 95.2%) 0.9515
Bacilli 4.8% (0.5 to 32.2%) 2.4% (0.1 to 78.8%) 0.2254
Lactobacillales 4.8% (0.5 to 32.2%) 2.2% (0.1 to 69.8%) 0.6264
Aerococcaceae 0% (0 to 1.6%) 0% (0 to 1.1%) 1.0000
Carnobacteriaceae 0% (0 to 0.2%) 0% (0 to 0.1%) 1.0000
Enterococcaceae 1.2% (0 to 14.5%) 0% (0 to 65.0%) 0.0080
Lactobacillaceae 0% (0 to 7.9%) 0% (0 to 5.6%) 0.0281
Leuconostocaceae 0% (0 to 0.2%) 0% (0%) 1.0000
Streptococcaceae 2.1% (0 to 31.2%) 1.6% (0 to 20.8%) 1.0000
Other 0.2% (0 to 1.7%) 0% (0 to 3.8%) 0.0234
Bacillales 0% (0 to 0.3%) 0% (0 to 0.8%) 0.9515
Paenibacillaceae 0% (0 to 0.2%) 0% (0 to 0.2%) 1.0000
Staphylococcaceae 0% (0 to 2.5%) 0.1% (0 to 8.2%) 1.0000
Bacillaceae 0% (0 to 0.3%) 0% (0 to 0.1%) 1.0000
Incertae Sedis XI 0% (0 to 0.2%) 0% (0 to 0.1%) 1.0000
Planococcaceae 0% (0%) 0% (0 to 0.2%) 1.0000
Other 0% (0 to 0.2%) 0% (0 to 0.2%) 1.0000
Other order 0% (0 to 0.1%) 0% (0 to 0.5%) 0.9515
Other family 0% (0 to 0.1%) 0% (0 to 0.5%) 1.0000
Clostridia 30.1% (3.4 to 64.5%) 18.8% (3.6 to 82.5%) 0.1314
Clostridiales 30.1% (3.4 to 64.5%) 29.5% (3.4 to 64.5%) 0.9515
Eubacteriaceae 0% (0 to 2.2%) 0% (0 to 1.2%) 0.3839
Lachnospiraceae 3.7% (0 to 55.5%) 5.6% (0.7 to 76.7%) 1.0000
Peptostreptococcaceae 3.4% (0 to 20.1%) 0% (0 to 12.4%) ,0.0001
Ruminococcaceae 0.2% (0 to 4.6%) 1.5% (0.1 to 18.5%) ,0.0001
Clostridiaceae 7.1% (0.1 to 45.2%) 5.4% (0 to 19.0%) 0.0080
Incertae Sedis XI 0% (0 to 1.1%) 1.2% (0 to 14.0%) ,0.0001
Incertae Sedis XIII 0% (0 to 0.8%) 0.1% (0 to 5.8%) 0.0080
Peptococcaceae 0% (0%) 0% (0 to 2.5%) 0.0438
Veillonellaceae 0% (0 to 8.3%) 0.9% (0 to 3.5%) ,0.0001
Other 3.1% (0.1 to 13.7%) 2.0% (0 to 16.5%) 1.0000
Other order 0% (0 to 0.4%) 0.2% (0 to 23.5%) 0.0190
Other family 0% (0 to 0.4%) 0.2% (0 to 23.5%) 0.0375
Erysipelotrichi 0.1% (0 to 1.0%) 0.1% (0 to 2%) 0.5376
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Table 2. Cont.
Microbial Phylum/Class/Order/Family 2-day-old foals (N=37) 30-day-old foals(N =37) P*
Erysipelotrichales 0.1% (0 to 1.0%) 0.1% (0 to 2%) 0.4844
Erysipelotrichiaceae 0.1% (0 to 1.0%) 0.1% (0 to 2%) 1.0000
Other class 0% (0 to 0.5%) 0.3% (0 to 6.5%) ,0.0001
Other order 0% (0 to 0.5%) 0.3% (0 to 6.5%) ,0.0001
Other family 0% (0 to 0.5%) 0.3% (0 to 6.5%) ,0.0001
Bacteria.Fusobacteria 0.8% (0 to 45.5%) 0.8% (0 to 42.5%) 0.9510
Fusobacteria 0.8% (0 to 45.5%) 0.8% (0 to 42.2%) 1.0000
Fusobacteriales 0.8% (0 to 45.5%) 0.8% (0 to 42.2%) 1.0000
Fusobacteriaceae 0.4% (0 to 45.3%) 0.8% (0 to 42.2%) 1.0000
Incertae sedis 11 0% (0 to 0.2%) 0% (0%) 1.0000
Other 0% (0 to 16.1%) 0% (0 to 1.0%) 1.0000
Bacteria.Lentisphaerae 0% (0%) 0% (0%) NP
Lentisphaerae 0% (0%) 0% (0%) NP
Victivallales 0% (0%) 0% (0%) NP
Victivallaceae 0% (0%) 0% (0%) NP
Bacteria. Other 0.2% (0 to 8.1%) 4.6% (0.2 to 68.5%) ,0.0001
Bacteria. Other Class 0.2% (0 to 8.1%) 4.6% (0.2 to 68.5%) ,0.0001
Other Order 0.2% (0 to 8.1%) 4.6% (0.2 to 68.5%) ,0.0001
Other family 0.2% (0 to 8.1%) 4.6% (0.2 to 68.5%) ,0.0001
Bacteria.Planctomycetes 0% (0 to 0.1%) 0% (0 to 1.4%) 0.0015
Planctomycetacia 0% (0 to 0.1%) 0% (0 to 1.4%) 0.0322
Planctomycetales 0% (0 to 0.1%) 0% (0 to 1.4%) 0.0047
Planctomycetaceae 0% (0 to 0.1%) 0% (0 to 1.4%) 0.0080
Bacteria.Proteobacteria 36.3% (0.5 to 85.8%) 2.7% (0 to 40.9%) ,0.0001
Alphaproteobacteria 0% (0 to 0.3%) 0% (0 to 0.3%) 0.8167
Caulobacterales 0% (0 to 0.2%) 0% (0) 0.9515
Caulobacteriaceae 0% (0 to 0.2%) 0% (0) 1.0000
Rhizobiales 0% (0 to 0.2%) 0% (0 to 0.2%) 0.9515
Hyphomicrobiaceae 0% (0%) 0% (0 to 0.1%) 1.0000
Methylobacteriaceae 0% (0 to 0.1%) 0% (0 to 0.1%) 1.0000
Other 0% (0 to 0.2%) 0% (0 to 0.3%) 1.0000
Rhodobacteriales 0% (0 to 0.2%) 0% (0 to 0.1%) 0.9515
Rhodobacteriaceae 0% (0 to 0.2%) 0% (0 to 0.1%) 1.0000
Rhodospirales 0% (0%) 0% (0%) NP
Other 0% (0%) 0% (0%) NP
Other order 0% (0%) 0% (0 to 0.1%) 0.9515
Other family 0% (0%) 0% (0 to 0.1%) 1.0000
Betaproteobacteria 0% (0 to 0.2%) 0% (0 to 0.5%) 0.4698
Burkholderiales 0% (0 to 0.2%) 0% (0 to 0.5%) 0.9230
Alcaligenaceae 0% (0 to 0.1%) 0% (0 to 0.1%) 1.0000
Comamonadacea 0% (0 to 0.1%) 0% (0 to 0.1%) 1.0000
Other 0% (0 to 0.1%) 0% (0 to 0.5%) 1.0000
Other order 0% (0 to 0.1%) 0% (0 to 0.1%) 0.9515
Other family 0% (0 to 0.1%) 0% (0 to 0.1%) 1.0000
Deltaproteobacteria 0% (0 to 0.4%) 0% (0 to 1.1%) 0.0084
Desulfovibrionales 0% (0 to 0.4%) 0% (0 to 0.5%) 0.0385
Desulfovibrionaceae 0% (0 to 0.4%) 0% (0 to 0.5%) 0.1136
Other 0% (0 to 0.1%) 0% (0 to 0.2%) 1.0000
Myxococcales 0% (0%) 0% (0 to 1.1%) 0.9515
Nannocystineae 0% (0%) 0% (0 to 1.0%) 1.0000
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Table 2. Cont.
Microbial Phylum/Class/Order/Family 2-day-old foals (N=37) 30-day-old foals(N =37) P*
Other 0% (0%) 0% (0 to 0.1%) 1.0000
Epsilonproteobacteria 0% (0 to 0.1%) 0.3% (0 to 16.4%) ,0.0001
Campylobacterales 0% (0 to 0.1%) 0.3% (0 to 16.4%) ,0.0001
Campylobacteriaceae 0% (0 to 0.1%) 0.2% (0 to 4.7%) ,0.0001
Helicobacteraceae 0% (%) 0% (0 to 15.9%) 0.0080
Gamma proteobacteria 36.3% (0 to 85.8%) 0.5% (0 to 40.9%) ,0.0001
Aeromonadales 0% (0 to 3.2%) 0% (0 to 4.2%) 0.9515
Aeromonadaceae 0% (0 to 3.2%) 0% (0%) 0.3234
Succinivibrionaceae 0% (0%) 0% (0 to 4.2%) 0.0080
Enterobacteriales 36.2% (0 to 85.8%) 0.1% (0 to 39.8%) ,0.0001
Enterobacteriaceae 36.2% (0 to 85.8%) 0.1% (0 to 39.8%) ,0.0001
Legionellales 0% (0%) 0% (0 to 0.2%) 0.9515
Coxiellaceae 0% (0%) 0% (0 to 0.1%) 1.0000
Legionellaceae 0% (0%) 0% (0 to 0.2%) 1.0000
Oceanospirillales 0% (0 to 0.1%) 0% (0%) 0.9515
Halomonadaceae 0% (0 to 0.1%) 0% (0%) 1.0000
Pasteurellales 0% (0 to 3.6%) 0% (0 to 1.2%) 0.9515
Pasteurellaceae 0% (0 to 3.6%) 0% (0 to 1.2%) 1.0000
Pseudomonadales 0% (0 to 1.5%) 0% (0 to 1.1%) 0.9515
Moraxellaceae 0% (0 to 0.3%) 0% (0 to 0.7%) 1.0000
Pseudomonadaceae 0% (0 to 1.2%) 0% (0 to 0.4%) 1.0000
Xanthomonadales 0% (0%) 0% (0 to 0.1%) 0.9515
Xanthomonadaceae 0% (0%) 0% (0 to 0.1%) 1.0000
Other order 0% (0 to 0.5%) 0% (0%) 0.3278
Other family 0% (0 to 0.5%) 0% (0%) 1.0000
Other class 0% (0 to 0.2%) 0% (0 to 23.7%) 0.0099
Other order 0% (0 to 0.2%) 0% (0 to 23.7%) 0.0333
Other family 0% (0 to 0.2%) 0% (0 to 23.7%) 0.9089
Bacteria.Spirochaetes 0% (0%) 0% (0 to 2.1%) 0.0100
Spirochaetes 0% (0%) 0% (0 to 2.1%) 0.0375
Spirochaetales 0% (0%) 0% (0 to 2.1%) 0.0360
Spirochaetaceae 0% (0%) 0% (0 to 2.1%) 0.0720
Other 0% (0%) 0% (0 to 0.2%) 1.0000
Bacteria.TM7 0% (0%) 0% (0 to 1.8%) 0.0048
TM7 genera incertae sedis 0% (0%) 0% (0 to 1.8%) 0.0280
Other order 0% (0%) 0% (0 to 1.8%) 0.0156
Other family 0% (0%) 0% (0 to 1.8%) 0.0308
Bacteria.Tenericutes 0% (0%) 0% (0 to 0.1%) 0.9515
Mollicutes 0% (0%) 0% (0 to 0.1%) 1.0000
Anaeroplasmatales 0% (0%) 0% (0 to 0.1%) 1.0000
Anaeroplasmataceae 0% (0%) 0% (0 to 0.1%) 1.0000
Bacteria.Verrucomicrobia 0% (0 to 42.5%) 1.0% (0.4 to 48.7%) 0.0015
Verrucomicrobiae 0% (0 to 42.5%) 1.0% (0.4 to 48.7%) 0.0322
Verrucomicrobiales 0% (0 to 42.5%) 1.0% (0.4 to 48.7%) 0.0040
Other 0% (0%) 0% (0 to 0.2%) 1.0000
Subdivision 5 0% (0 to 0.2%) 0.3% (0 to 25.4%) 0.0000
Verrucomicrobiaceae 0% (0 to 42.5%) 0.6% (0 to 48.6%) 0.0158
Xiphinematobacteriaceae 0% (0%) 0% (0 to 0.2%) 1.0000
Other Kingdom, Other phylum 0% (0 to 1.1%) 0% (0 to 0.3%) 0.9515
Other class 0% (0 to 1.1%) 0% (0 to 0.3%) 1.0000
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approximately 2 to 3 inches into the rectum, and swabbing the
rectal mucosa circumferentially by rotating the swab. Once the
cotton swab was removed, the cotton tip was separated from the
handle using scissors and the tip was placed inside the barrel of a
35-ml catheter-tip syringe; the syringe plunger was used to squeeze
the liquid from the swab tip, and the liquid was collected into a
sterile tube. Fecal swab samples were collected on days 2 and 30 of
life from foals in all groups. For 2 foals in the control group
without CTB, fecal swab samples were collected on days 2, 9, 16,
23, 30, and 56 following birth. All fecal solutions were frozen at -
80uC until processed.
Fecal DNA extraction
DNA was extracted by a bead-beating method using the ZR
Fecal DNA MiniPrep Kit (Zymo Research Corporation) per the
manufacturer’s instructions. The bead-beating step was performed
using a homogenizer (FastPrep-24, MP Biomedicals) for 60 s at
speed of 4 m/s.
Microbiome analysis
Bacterial tag-encoded FLX-titanium amplicon pyrosequencing
(bTEFAP) was performed as described previously [31] based upon
the V4-V6 region (E. coli position 530 – 1100) of the 16S rRNA
gene, with primers forward 530F: GTGCCAGCMGCNGCGG
and reverse 1100R: GGGTTNCGNTCGTTR.
Raw sequence data were screened, trimmed, filtered, de-noised,
and chimera-depleted with default settings using the QIIME
pipeline version 1.6.0 (http://qiime.sourceforge.net) and with
USEARCH using the OTU pipeline (www.drive5.com). Opera-
tional taxonomic units (OTUs) were defined as sequences with at
least 97% similarity using QIIME. For classification of sequences
on a genus level the naı¨ve Bayesian classifier within the Ribosomal
Database Project (RDP, v10.28) was used [31].
The obtained data were compiled to determine the relative
proportions of bacteria for each individual sample. The subse-
quent analysis was performed on a randomly selected subset of
1,300 sequences per sample to account for unequal sequencing
depth across samples. Alpha diversity and beta diversity measures
were calculated and plotted using QIIME. To determine
differences in microbiota composition between the animal groups,
the analysis of similarities (ANOSIM) function in the statistical
software package PRIMER 6 (PRIMER-E Ltd., Lutton, UK) was
used on the unweighted Unifrac distances matrices. This analysis
measures the phylogenetic distance among bacterial communities
in a phylogenetic tree, and thereby provides a measure of
similarity among microbial communities present in different
biological samples. The linear discriminant analysis (LDA) effect
size (LEfSe) method was used to represent taxonomic relevant age-
related differences in foal fecal swabs [32].
qPCR
To validate the pyrosequencing results, quantitative PCR
(qPCR) assays were performed as described previously [33].
Briefly, EvaGreen-based reaction mixtures (total 10 mL) contained
5 mL of SsoFastTM EvaGreenH supermix (Biorad Laboratories),
2.2 mL of water, 0.4 mL of each primer (final concentration:
400 nM), and 2 mL of DNA (normalized to 5 ng/ul)). PCR
conditions were 98uC for 2 min, and 40 cycles at 98uC 5 s, and 5 s
at the optimized annealing temperature (Table 1). A melt curve
analysis was performed for under the following conditions:
beginning at 65uC, gradually increasing 0.5uC/5 s to 95uC with
acquisition data every 5 s. The qPCR data was expressed as log
amount of DNA (fg) for each particular bacterial group per 10 ng
of isolated total DNA [34].
Data analysis
Pairwise comparisons between ages 2 days and 30 days were
made at the levels of phylum, class, order, and family of bacteria
for 2 outcomes: the observed percentage of sequences of bacteria
at a given level, and the proportion of foals in which any amount
of a given sequence for a given level was observed (i.e., the
dichotomous outcome of whether or not a specific phylum [or
class or order or family] was represented). The paired differences
in percentages were compared using a Wilcoxon sign-rank test,
and the paired proportions were compared using McNemar’s test.
Because of the multiplicity of comparisons, P values at a given level
(e.g., order) were adjusted using the method of Hochberg [35]. An
adjusted P value ,0.05 was considered significant for these
analyses. Analyses were conducted using S-PLUS (Version 8.0;
Insightful, Inc.) and R (Version 2.12.1; R Statistical Project). To
assess the diversity of the GI microbiota, the Shannon-Weaver
[36] and Chao 1 [37] diversity indices were calculated in QIIME.
Results
Sequence analysis
The 454-pyrosequencing pipeline yielded 499,419 quality
sequences for the 42 samples analyzed. For technical reasons
attributed to random error, 5 foals (2 foals from the control group
without CTB, and 3 foals from the live R. equi group) did not
generate sufficient sequences (cut-off value of 1,300 sequences) in
at least 1 sample from 1 sampling time-point (either 2 or 30 days)
by 454-pyrosequencing. Those foals were included in the
descriptive analysis (Figures PCoA and rarefaction). For compar-
ing age-related changes of the microbiome, however, the analysis
was restricted to 37 foals with samples available from both
collection time-points (2 and 30 days).
Across all vaccination groups and ages, sequences were classified
into 18 phyla (Table 2 and 3). For the rarefaction curves of all
vaccination groups (Figure 1A and 1B) and age groups (Figure 2),
1,300 sequences per sample yielded stable estimates of sample
diversity.
Table 2. Cont.
Microbial Phylum/Class/Order/Family 2-day-old foals (N=37) 30-day-old foals(N =37) P*
Other order 0% (0 to 1.1%) 0% (0 to 0.3%) 1.0000
Other family 0% (0 to 1.1%) 0% (0 to 0.3%) 1.0000
Fecal swab samples were collected from 37 Quarter Horse foals on days 2 and 30 of life. *P values represent the results of Wilcoxon sign-rank tests for paired differences,
adjusted by the method of Hochberg. NP = Not Performed.
doi:10.1371/journal.pone.0066640.t002
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Table 3. Median and range proportion of foals with sequences detected in the fecal DNA of rectal swab samples (Phylum, class,
order, and family).
Microbial Family 2-day-old foals (N=37) 30-day-old foals (N=37) P*
Archaea.Euryarchaeota 0% (0/37) 35% (13/37) 0.0117
Methanobacteria 0% (0/37) 24% (9/37) 0.0770
Methanobacteriales 0% (0/37) 24% (9/37) 0.1925
Methanobacteriacae 0% (0/37) 24% (9/37) 0.4851
Methanomicrobia 0% (0/37) 16% (6/37) 0.3708
Methanomicrobiales 0% (0/37) 16% (6/37) 0.9064
Methanocorpusculaceae 0% (0/37) 16% (6/37) 1.0000
Bacteria.Acidobacteria 0% (0/37) 3% (1/37) 0.9999
Acidobacteria 0% (0/37) 3% (1/37) 1.0000
Acidobacteriales 0% (0/37) 3% (1/37) 1.0000
Acidobacteriaceae 0% (0/37) 3% (1/37) 1.0000
Bacteria.Actinobacteria 73% (27/37) 97% (36/37) 0.1590
Actinobacteria 73% (27/37) 97% (36/37) 0.1925
Actinomycetales (order) 62% (23/37) 73% (27/37) 1.0000
Bifidobacteriales (order) 3% (1/37) 8% (3/37) 1.0000
Other 14% (5/37) 8% (3/37) 1.0000
Coriobacteridae (subclass) 24% (9/37) 76% (28/37) 0.0041
Coriobacteriales 24% (9/37) 76% (28/37) 0.0221
Rubrobacteridae (subclass) 3% (1/37) 0% (0/37) 1.0000
Rubrobacterales 3% (1/37) 0% (0/37) 1.0000
Other order 0% (0/37) 27% (10/37) 0.1452
Other family 0% (0/37) 27% (10/37) 0.2944
Bacteria.Bacteroidetes 92% (34/37) 100% (37/37) 0.5152
Bacteroidetes 89% (33/37) 100% (37/37) 1.0000
Bacteroidales 89% (33/37) 100% (37/37) 1.0000
Bacteroidieacae 86% (32/37) 95% (35/37) 1.0000
Porphyromonadaceae 30% (11/37) 89% (33/37) ,0.0001
Prevotellaceae 8% (3/37) 95% (35/37) ,0.0001
Rikenellaceae 11% (4/37) 49% (18/37) 0.1496
Other 11% (4/37) 95% (35/37) ,0.0001
Flavobacteria 16% (6/37) 11% (4/37) 1.0000
Flavobacteriales 16% (6/37) 11% (4/37) 1.0000
Flavobacteriaceae 16% (6/37) 11% (4/37) 1.0000
Sphingobacteria 5% (2/37) 3% (1/37) 1.0000
Sphingobacteriales 5% (2/37) 3% (1/37) 1.0000
Crenotrichaceae 3% (1/37) 0% (0/37) 1.0000
Flexibacteriaceae 0% (0/37) 3% (1/37) 1.0000
Sphingobacteriaceae 3% (1/37) 0% (0/37) 1.0000
Other class 27% (10/37) 95% (35/37) ,0.0001
Other order 27% (10/37) 95% (35/37) ,0.0001
Other family 27% (10/37) 95% (35/37) ,0.0001
Bacteria.Chlamydiae 0% (0/37) 51% (19/37) ,0.0001
Chlamydiae 0% (0/37) 51% (19/37) ,0.0001
Chlamydiales 0% (0%) 51% (19/37) ,0.0001
Chlamydiaceae 0% (0%) 51% (19/37) ,0.0001
Parachlamydiaceae 0% (0%) 3% (1/37) 1.0000
Bacteria.Chloroflexi 0% (0/37) 22% (8/37) 0.1463
Anaerolineae 0% (0/37) 22% (8/37) 0.1173
Caldilineae 0% (0/37) 3% (1/37) 1.0000
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Table 3. Cont.
Microbial Family 2-day-old foals (N=37) 30-day-old foals (N=37) P*
Caldilineales 0% (0/37) 3% (1/37) 1.0000
Other 0% (0/37) 19% (7/37) 0.7223
Other family 0% (0/37) 19% (7/37) 1.0000
Bacteria.Cyanobacteria 0% (0/37) 3% (1/37) 0.9999
Cyanobacteria 0% (0/37) 3% (1/37) 1.0000
Other order 0% (0/37) 3% (1/37) 1.0000
Other family 0% (0/37) 3% (1/37) 1.0000
Bacteria.Deferribacteres 3% (1/37) 5% (2/37) 0.9999
Deferribacteres 3% (1/37) 5% (2/37) 1.0000
Deferribacterales 3% (1/37) 5% (2/37) 1.0000
Deferribacteraceae 0% (0%) 0% (0%) NP
Incertae sedis 3 3% (1/37) 5% (2/37) 1.0000
Bacteria.Fibrobacteres 0% (0/37) 14% (5/37) 0.5152
Fibrobacteres 0% (0/37) 14% (5/37) 0.4698
Fibrobacterales 0% (0/37) 14% (5/37) 0.9515
Fibrobacteraceae 0% (0/37) 14% (5/37) 1.0000
Bacteria.Firmicutes 100% (37/37) 100% (37/37) NP
Bacilli 100% (37/37) 100% (37/37) NP
Lactobacillales 100% (37/37) 100% (37/37) NP
Aerococcaceae 27% (10/37) 14% (5/37) 1.0000
Carnobacteriaceae 14% (5/37) 3% (1/37) 1.0000
Enterococcaceae 95% (35/37) 41% (15/37) 0.0078
Lactobacillaceae 27% (10/37) 70% (26/37) 0.2944
Leuconostocaceae 8% (3/37) 0% (0/37) 1.0000
Streptococcaceae 97% (36/37) 97%(36/37) 1.0000
Other 78% (29/37) 22% (8/37) ,0.0001
Bacillales 46% (17/37) 70% (26/37) 1.0000
Paenibacillaceae 3% (1/37) 5% (2/37) 1.0000
Staphylococcaceae 32% (12/37) 62% (23/37) 1.0000
Bacillaceae 14% (5/37) 14% (5/37) 1.0000
Incertae Sedis XI 11% (4/37) 3% (1/37) 1.0000
Planococcaceae 3% (1/37) 11% (4/37) 1.0000
Other 0% (0/37) 8% (3/37) 1.0000
Other order 30% (11/37) 11% (4/37) 1.0000
Other family 30% (11/37) 11% (4/37) 1.0000
Clostridia 100% (37/37) 100% (37/37) NP
Clostridiales 100% (37/37) 100% (37/37) NP
Eubacteriaceae 5% (2/37) 35% (13/37) 0.6076
Lachnospiraceae 89% (33/37) 100% (37/37) 1.0000
Peptostreptococcaceae 43% (16/37) 0.0150
Ruminococcaceae 70% (26/37) 100% (37/37) 0.1716
Clostridiaceae 100% (37/37) 78% (29/37) 0.7980
Incertae Sedis XI 11% (4/37) 78% (29/37) ,0.0001
Incertae Sedis XIII 5% (2/37) 57% (21/37) 0.0154
Peptococcaceae 0% (0/37) 32% (12/37) 0.1065
Veillonellaceae 16% (6/37) 95% (35/37) ,0.0001
Other 100% (37/37) 97% (36/37) 1.0000
Other order 32% (12/37) 59% (22/37) 0.8136
Other family 32% (12/37) 59% (22/37) 1.0000
Erysipelotrichi 62% (23/37) 70% (26/37) 1.0000
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Table 3. Cont.
Microbial Family 2-day-old foals (N=37) 30-day-old foals (N=37) P*
Erysipelotrichales 62% (23/37) 70% (26/37) 1.0000
Erysipelotrichiaceae 62% (23/37) 70% (26/37) 1.0000
Other class 49% (18/37) 86% (32/37) 0.0242
Other order 49% (18/37) 86% (32/37) 0.0594
Other family 49% (18/37) 86% (32/37) 1.0000
Bacteria.Fusobacteria 62% (23/37) 84% (31/37) 0.5152
Fusobacteria 62% (23/37) 84% (31/37) 1.0000
Fusobacteriales 62% (23/37) 84% (31/37) 1.0000
Fusobacteriaceae 62% (23/37) 81% (30/37) 1.0000
Incertae sedis 11 5% (2/37) 0% (0/37) 1.0000
Other 32% (12/37) 43% (16/37) 1.0000
Bacteria.Lentisphaerae 0% (0/37) 0% (0/37) NP
Lentisphaerae 0% (0/37) 0% (0/37) NP
Victivallales 0% (0/37) 0% (0/37) NP
Victivallaceae 0% (0/37) 0% (0/37) NP
Bacteria.Other 86% (32/37) 100% (37/37) 0.5152
Bacteria. Other Class 86% (32/37) 100% (37/37) 1.0000
Other Order 86% (32/37) 100% (37/37) 1.0000
Other family 86% (32/37) 100% (37/37) 1.0000
Bacteria.Planctomycetes 3% (1/37) 43% (16/37) 0.0045
Planctomycetacia 3% (1/37%) 43% (16/37) 0.0377
Planctomycetales 3% (1/37) 43% (16/37) 0.0120
Planctomycetaceae 3% (1/37) 43% (16/37) 0.0003
Bacteria.Proteobacteria 100% (37/37) 97% (36/37) 0.9999
Alphaproteobacteria 11% (4/37) 14% (5/37) 1.0000
Caulobacterales 3% (1/37) 0% (0/37) 1.0000
Caulobacteriaceae 3% (1/37) 0% (0/37) 1.0000
Rhizobiales 5% (2/37) 8% (3/37) 1.0000
Hyphomicrobiaceae 0% (0/37) 3% (1/37) 1.0000
Methylobacteriaceae 3% (1/37) 3% (1/37) 1.0000
Other 3% (1/37) 3% (1/37) 1.0000
Rhodobacteriales 5% (2/37) 3% (1/37) 1.0000
Rhodobacteriaceae 5% (2/37) 3% (1/37) 1.0000
Rhodospirales 0% (0%) 0% (0%) NP
Other 0% (0%) 0% (0%) NP
Other order 0% (0%) 3% (1/37) 1.0000
Other family 0% (0%) 3% (1/37) 1.0000
Betaproteobacteria 11% (4/37) 27% (10/37) 1.0000
Burkholderiales 8% (3/37) 24% (9/37%) 1.0000
Alcaligenaceae 3% (1/37) 3% (1/37) 1.0000
Comamonadacea 3% (1/37) 8% (3/37) 1.0000
Other 3% (1/37) 14% (5/37) 1.0000
Other order 5% (2/37) 3% (1/37) 1.0000
Other family 5% (2/37) 3% (1/37) 1.0000
Deltaproteobacteria 5% (2/37) 49% (18/37) 0.0104
Desulfovibrionales 5% (2/37) 46% (17/37) 0.0377
Desulfovibrionaceae 5% (2/37) 43% (16/37) 0.1496
Other 3% (1/37) 14% (5/37) 1.0000
Myxococcales 0% (0/37) 3% (1/37) 1.0000
Nannocystineae 0% (0/37) 3% (1/37) 1.0000
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Table 3. Cont.
Microbial Family 2-day-old foals (N=37) 30-day-old foals (N=37) P*
Other 0% (0/37) 0% (0/37) NP
Epsilonproteobacteria 3% (1/37) 73% (27/37) ,0.0001
Campylobacterales 3% (1/37) 73% (27/37) ,0.0001
Campylobacteriaceae 3% (1/37) 65% (24/37) ,0.0001
Helicobacteraceae 0% (0/37) 43% (16/37) 0.0154
Gamma proteobacteria 97% (36/37) 89% (33/37) 1.0000
Aeromonadales 22% (8/37) 41% (15/37) 1.0000
Aeromonadaceae 22% (8/37) 0% (0/37) 0.7980
Succinivibrionaceae 0% (0/37) 41% (15/37) 0.0219
Enterobacteriales 95% (35/37) 62% (23/37) 0.0858
Enterobacteriaceae 95% (35/37) 62% (23/37) 0.2145
Legionellales 0% (0/37) 5% (2/37) 1.0000
Coxiellaceae 0% (0/37) 3% (1/37) 1.0000
Legionellaceae 0% (0/37) 3% (1/37) 1.0000
Oceanospirillales 3% (1/37) 0% (0/37) 1.0000
Halomonadaceae 3% (1/37) 0% (0/37) 1.0000
Pasteurellales 32% (12/37) 38% (14/37) 1.0000
Pasteurellaceae 32% (12/37) 38% (14/37) 1.0000
Pseudomonadales 14% (5/37) 11% (4/37) 1.0000
Moraxellaceae 14% (5/37) 11% (4/37) 1.0000
Pseudomonadaceae 5% (2/37) 3% (1/37) 1.0000
Xanthomonadales 0% (0/37) 3% (1/37) 1.0000
Xanthomonadaceae 0% (0/37) 3% (1/37) 1.0000
Other order 16% (6/37) 0% (0/37) 0.9064
Other family 16% (6/37) 0% (0/37) 1.0000
Other class 5% (2/37) 43% (16/37) 0.0242
Other order 5% (2/37) 43% (16/37) 0.0594
Other family 5% (2/37) 43% (16/37) 0.1496
Bacteria.Spirochaetes 0% (0/37) 30% (11/37) 0.0312
Spirochaetes 0% (0/37) 30% (11/37) 0.0439
Spirochaetales 0% (0/37) 30% (11/37) 0.0910
Spirochaetaceae 0% (0/37) 30% (11/37) 0.1716
Other 0% (0/37) 3% (1/37) 1.0000
Bacteria.TM7 0% (0/37) 35% (13/37) 0.0117
TM7 genera incertae sedis 0% (0/37) 35% (13/37) 0.0218
Other order 0% (0/37) 35% (13/37) 0.0351
Other family 0% (0/37) 35% (13/37) 0.0648
Bacteria.Tenericutes 0% (0/37) 3% (1/37) 1.0000
Mollicutes 0% (0/37) 3% (1/37) 1.0000
Anaeroplasmatales 0% (0/37) 3% (1/37) 1.0000
Anaeroplasmataceae 0% (0/37) 3% (1/37) 1.0000
Bacteria.Verrucomicrobia 24% (9/37) 89% (33/37) ,0.0001
Verrucomicrobiae 24% (9/37) 89% (33/37) ,0.0001
Verrucomicrobiales 24% (9/37) 89% (33/37) ,0.0001
Other 0% (0%) 5% (2/37) 1.0000
Subdivision 5 8% (3/37) 76% (28/37) ,0.0001
Verrucomicrobiaceae 16% (6/37) 78% (29/37) ,0.0001
Xiphinematobacteriaceae 0% (0%) 3% (1/37) 1.0000
Other Kingdom, Other phylum 19% (7/37) 22% (8/37) 0.9999
Other class 19% (7/37) 22% (8/37) 1.0000
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Microbial communities in control and vaccinated foals
No differences in microbial composition were observed among
animals from control, live and inactivated treatment/vaccination
groups (Figures 1A, 1B, and 3). The rarefaction curves for the
treatment groups revealed no clear pattern of greater number of
observed species (i.e., diversity) among foals receiving either live or
inactivated R. equi, or those foals in the 3 control groups that did
not receive R. equi (Figure 1A). Because the samples at age 2 days
were not affected by treatment (because treatment was adminis-
tered after sample collection on day 2), we also performed analysis
restricting data to samples collected at age 30 days (Figure 1B).
Once again, there was no pattern of differences in the rarefaction
curves among treatment groups receiving either live or inactivated
R. equi or the control groups. Using PCoA (Figures 3 and 4), there
was no qualitative evidence of differences among groups; the
clustering observed in Figure 3 panel A was attributable to effects
of age (please see next section). When considering only the data
from foals at 30 days of age (because samples on day 2 were
collected prior to treatment administration), the PCoA plots
revealed no clustering by group and the ANOSIM test statistic for
differences among groups was not significant (P = 0.494).
Age-related changes in microbial communities in foals
There were strong and significant differences in the fecal
microbiome of foals associated with age. The rarefaction curves
demonstrated a pattern of increasing number of species (diversity)
with increasing age (Figure 2). These results should be interpreted
with caution because there were only 2 foals for which data for
ages other than 2 days and 30 days were available. The PCoA
plots by age revealed an obvious separation of samples by age,
attributable to differences between the time-points of days 2 and
30 (Figure 5); the ANOSIM test statistic for differences between
day 2 and day 30 was significant (P = 0.0010).
Significant differences in the number of OTUs, the Shannon
index, and the Chao1 metric were observed between the age
groups (Table 4). The median number of OTUs for 2day-old foals
(92 OTUs; range, 50 to 195 OTUs) was significantly (P,0.0001)
lower than that for 30-day-old foals (201 OTUs; range, 94 to 318
OTUs). The Shannon Index for the foals studied also increased
significantly (P,0.0001) from 2 days of life (median, 2.37; range,
1.24 to 3.97) to 30 days of life (median, 3.7; range, 1.90 to 4.80).
Similarly, there was a significant (P,0.0001) age-related increase
in Chao 1 values between 2-day-old foals (median, 206.54; range,
128.16 to 415.70) and 30-day-old foals (median, 362.38; range,
197.42 to 581.43).
Because of the apparent differences of the microbiota between
age groups, we also compared the distribution of bacteria by
phylum, class, order, and family between foals aged 2 days and 30
days. In total, 18 phyla were detected in fecal samples from foals
(Table 2). Of those, Bacteroidetes (40.6%, day 30), Firmicutes
(40.4%, day 2), and Proteobacteria (36.6%, day 2) had the highest
percentages of sequences reported. Proteobacteria and Firmicutes
were detected in all samples from 2-day-old foals, followed by
Bacteroidetes (92%) and Actinobacteria (73%) (Table 3). Among
30-day-old foals, Bacteroidetes and Firmicutes were detected in all
fecal samples, followed by Actinobacteria (97%) and Proteobac-
teria (97%), Verrucomicrobia (89%), and Fusobacteria (84%)
(Table 3). The following phyla increased significantly with age (i.e,
Table 3. Cont.
Microbial Family 2-day-old foals (N=37) 30-day-old foals (N=37) P*
Other order 19% (7/37) 22% (8/37) 1.0000
Other family 19% (7/37) 22% (8/37) 1.0000
Fecal swab samples collected from 37 Quarter Horse foals on days 2 and 30 of life. *P values represent the results of McNemar’s test for paired dichotomous data,
adjusted by the method of Hochberg. NP = Not Performed.
doi:10.1371/journal.pone.0066640.t003
Figure 3. Principal coordinates analysis (PCoA) of unweighted UniFrac distances of 16 S rRNA genes. Analysis for 42 foals in groups
control with CTB (red square), control without CTB (yellow triangle), low-dose inactivated R. equi (dark blue triangle), high-dose inactivated R. equi 2
(green dot), and live R. equi (light blue triangle) at 2 and 30 days of age (ANOSIM, P = 0.236). The 3 panels represent the comparison of the first 2
principal components (A), the second and third principal components (B), and the first and third principal components (C). The pattern in the panel A
is attributable to effects of age (please see Figures 4 and 5).
doi:10.1371/journal.pone.0066640.g003
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from 2 days to 30 days of age): Euryarchaeota, Actinobacteria,
Bacteroidetes, Chlamydiae, Chloroflexi, Planctomycetes, Spiro-
chaetes, TM7, and Verrucomicrobia. Proteobacteria was the only
phylum that decreased significantly with age. Other classes, orders,
and families also showed statistically significant age-related
changes (Table 2 and Figure 6).
Within the phylum Proteobacteria, the class Gammaproteo-
bacteria (P,0.0001) and the family Enterobacteriaceae
(P,0.0001) decreased significantly with age. Other classes of
Proteobacteria, such as Deltaproteobacteria (P = 0.0084) and
Epsilonproteobacteria (P,0.0001) significantly increased with
age (Table 2).
To confirm results of pyrosequencing, we also performed real-
time quantitative PCR. Significant differences were observed in
specific microbial communities between the 2 age groups based on
qPCR analysis, with age-related decreases for Escherichia coli
(P,0.0001) and for Enterococcus (P,0.0001). These data were
consistent with genus-level results observed by pyrosequencing
(Table 5) for Enterococcus (P = 0.0009) and for Escherichia
(P,0.0001). We also found agreement for a lack of evidence of
a significant difference between the pyrosequencing and the qPCR
results for Bacteroidetes (P = 0.9519 by qPCR and P = 0.5376 by
pyrosequencing) and Fusobacteria (P = 0.1051 on qPCR and
P = 0.1000 on pyrosequencing).
Discussion
In this study, our first objective was to evaluate changes in the
microbiome of foals following vaccination with both live and
inactivated R. equi. Although the number of CFUs administered
were as high (for the live R. equi group) or higher than the number
of CFU documented to protect foals against intrabronchial
challenge with virulent R. equi (viz., 161010 CFU), no apparent
differences in microbial communities were observed among
vaccinated groups (Figures 1A and 3). Because all but 2 foals
had samples collected only on days 2 and 30, and because fecal
Figure 4. Principal coordinates analysis (PCoA) of unweighted UniFrac distances of 16 S rRNA genes. Analysis for 42 foals in groups
control with CTB (red square), control without CTB (yellow triangle), low-dose inactivated R. equi (dark blue triangle), high-dose inactivated R. equi 2
(green dot), and live R. equi (light blue triangle) at 30 days of age only. Differences among groups were not significant (ANOSIM, P = 0.449). The 3
panels represent the comparison of the first 2 principal components (A), the second and third principal components (B), and the first and third
principal components (C).
doi:10.1371/journal.pone.0066640.g004
Figure 5. Principal coordinates analysis (PCoA) of unweighted UniFrac distances of 16 S rRNA genes. Analysis for 42 foals at 2 (red
triangle), 7 days old (yellow triangle), 14 (green dot), 21 (green triangle), 30 (light blue square), and 56 days of age (dark blue triangle). The 3 panels
represent the comparison of the first 2 principal components (A), the second and third principal components (B), and the first and third principal
components (C). Strong effects of age can be seen in panels A and C, and differences among age groups were significant (ANOSIM, P = 0.0010).
doi:10.1371/journal.pone.0066640.g005
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samples on day 2 were not influenced by treatment (because they
were collected immediately prior to treatment), the effect of group
also was examined among only samples collected at 30 days of age.
Results restricted to 30 days of age also revealed no pattern
distinguishing vaccinated and non-vaccinated foals (Figures 1B
and 4). Thus, we failed to detect evidence of a significant effect of
enteral administration of either live or inactivated R. equi on
microbial populations in neonatal foals. These results are
consistent with reports in which probiotics (administered at similar
or higher numbers of CFUs) have failed to alter the intestinal/fecal
microbiome [38–40]. Our results should be interpreted with
caution because of the relatively small number of foals, particularly
in the live R. equi group. For technical reasons attributed to
random error, pyrosequencing failed for samples from 3 foals from
the live R. equi group and 2 foals from the control group without
CTB group; therefore, only 3 foals from the live R. equi group and
Table 4. Summary of alpha diversity measures.
Index 2 day-old 30 day-old P
Chao 1 (median, range) 206.54 (128.16 to 415.70) 362.38 (197.42 to 581.43) ,0.0001
OTUs (median, range) 92 (50 to 195) 201 (94 to 318) ,0.0001
Shannon H (median, range) 2.37 (1.24 to 3.97) 3.7 (1.90 to 4.80) ,0.0001
doi:10.1371/journal.pone.0066640.t004
Figure 6. LEfSe results on foal microbiome. Rotary phylogenetic representation of the predominate microbial composition of fecal samples
from foals at 2 days of age (A, red) and 30 days of age (C, green) [32].
doi:10.1371/journal.pone.0066640.g006
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6 from the controls without CTB group were included in the
analysis.
A significant difference between the fecal microbial populations
between day 2 and day 30 of age was observed (Table 2 and 3;
Figures 2, 5, and 6). For descriptive purposes, we included the
results from the 2 foals from which we had data at other ages (these
data were not included in the statistical analysis comparing ages).
The resident intestinal or fecal microbiota has been described for
neonates of other species, such as cats [41,42], dogs [43], and
humans [25–27,44]. To the authors’ knowledge, this is the first
report of age-related changes of the fecal microbiome in foals.
Significant changes in the number of OTUs, the Shannon index,
and the Chao1 metric were observed between the age groups
(Table 4), showing clear evidence of strong diversification of
bacterial populations between 2 and 30 days of age.
Firmicutes were detected in 100% of foals at both 2 and 30 days
of age, with reported median sequences of 40% in 2-day-old foals
decreasing (albeit not significantly) to 23% in 30-day-old foals. In 2
previous studies using fecal samples from adult horses, Firmicutes
represented 44% [45] and 72% [46] of the bacteria. Within the
Firmicutes, the family Enterococcaceae significantly decreased
with age (P = 0.0080), which was likely attributable at least in part
to decreases in the genus Enterococcus that were observed to
decrease significantly by qPCR (P,0.0001) and by pyrosequenc-
ing (Table 5). Proteobacteria were detected in the feces of all 2-
day-old foals and 97% of 30-day-old foals, a difference that was
not significant; however, the median percentage of sequences
decreased significantly (P,0.0001) between day 2 (median, 36.3%;
range, 0.5 to 85.8%) and day 30 (median, 2.7%; range, 0 to
40.9%). In adult horses, Proteobacteria have been reported to
represent 6% [45] and 12% [47] of fecal sequences. These results
from adult horses are interesting in light of our findings,
particularly our observation that the family Enterobacteriaceae
decreased with age, a finding substantiated by our qPCR results
with a significant decrease in the amount of E. coli (P,0.0001)
between ages 2 and 30 days.
The sterile GI tract of newborn puppies and kittens is
presumably colonized by bacteria present in the birth canal and
from the environment [48], and human neonates appear to
become colonized by these sources as well as through the intestinal
microbiota of the mother [25,49]. In humans, the initial microbes
colonizing infants are facultative anaerobic bacteria, such as E. coli
and Streptococcus spp. [49], which was also observed in 2-day old
foals by the presence of Enterobacteriaceae (E. coli) and
Streptococcaceae families (Streptococcus spp.). We observed a
significant decrease in both these families by 30 days of age,
suggesting that a similar phenomenon might happen in foals. In
human beings, after the initial colonization by facultative
anaerobic bacteria, colonization occurs by Staphylococcus-, Entero-
coccus-, and Lactobacillus-like species, and this change might
contribute to generating an anaerobic environment [44]. The
development during the first month of life in foals of an anaerobic
environment is supported by the age-related increase in the
detection of the phylum of Bacteroidetes (P = 0.0066), which is also
a common constituent of the gut microbiota of dogs and cats [48].
However, we also observed a significant decrease in the
Enterococcaceae family (P = 0.0080) and Enterococcus spp. by
qPCR (P,0.0001), as well as the Lactobacillaceae family
(P = 0.0281).
Our study has a number of important limitations. One
limitation is the use of fecal swab samples for analysis, because
feces might not be representative of other compartments of the
gut. In humans, the composition of the mucosal-surface microbi-
ota is distinct from that recovered in the feces [50]. The situation is
probably similar in the horse, because of the complexity of the
equine gastrointestinal tract. For example, the microbial popula-
tion of adult horse fecal samples is likely to represent that of the
right dorsal colon, but not that of the cecum [51].
A second limitation of our study is the small number of foals
enrolled. Our sample size was limited both by financial
considerations and the number of foals available to us during
the study period. Because of the small sample size, we were only
able to observe large changes in fecal microbial populations.
Nevertheless, our results provide useful data for those exploring
enteral vaccination of foals [14,52]. It is worth noting that there
were significant differences in immune responses that were
detectable among these groups of foals despite the small sample
size (data not shown). Also, we were able to detect significant age-
related differences in the microbiome of foals, irrespective of the
treatment groups.
Another limitation of our study is that we only characterized
age-related changes at 2 ages during the first month of life.
Although our data from 2 foals with more frequent sampling
appears to demonstrate a progressive diversification of microbial
flora with age (Figure 5), further studies using more foals with
more frequent sampling times are needed to better characterize
microbial diversification. Our focus on the first month of life was
based on current understanding that vaccination of foals against R.
equi will have to occur during early life [53].
In conclusion, no differences were observed in the fecal
microbiome of foals following enteral vaccination with either live
or inactivated R. equi. These results demonstrate that administra-
tion of the doses of bacteria used in this study does not likely cause
an alteration of the fecal microbiome of foals. More notably, the
results indicate significant age-related changes in the microbiome
composition of foals during the first month of life.
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Table 5. Results of qPCR analysis.
Medians (min-max) log DNA (qPCR)
2 day-old 30 day-old P*
Universal 13.2 (11.0 to 14.5) 12.3 (9.3 to 14.2) 0.0108
Bacteroidetes 11.4 (8.4 to 12.9) 11.2 (9.3 to 12.4) 0.9519
Enterococcus 7.9 (6.5 to 9.3) 5.7 (4.1 to 7.3) ,0.0001
Escherichia 8.2 (4. 3 to 8.9) 5.3 (2.8 to 6.5) ,0.0001
Fusobacteria 8.6 (6.0 to 10.4) 7.8 (6.4 to 9.7) 0.1051
Median (range) of log DNA. *P value for Wilcoxon rank-sum test comparing
differences between ages day 30 and day 2, adjusted by the method of
Hochberg.
doi:10.1371/journal.pone.0066640.t005
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